Literature DB >> 17521611

Characterization of transcriptional regulatory domains of ankyrin repeat cofactor-1.

Aihua Zhang1, Chia-Wei Li, J Don Chen.   

Abstract

The ankyrin repeats cofactor-1 (ANCO-1) was recently identified as a p160 coactivator-interacting protein that may inhibit transcriptional activity of nuclear receptors. Here, we have characterized the transcriptional regulatory domains of ANCO-1. Two intrinsic repression domains (RD) were identified: an N-terminal RD1 at residues 318-611 and a C-terminal RD2 at 2369-2663. ANCO-1 also contains an activation domain (AD) capable of stimulating transcription in both mammalian and yeast cells. The minimal AD was delimited to a 70-amino acid region at residues 2076-2145. Overall, full-length ANCO-1 exhibited transcriptional repressor activity, suggesting that RD domains may suppress the AD activity. We further demonstrated that ANCO-1 silencing by siRNA enhanced progesterone receptor-mediated transcription. Together, these results indicate that the transcriptional potential of ANCO-1 may be modulated by a combination of repression and activation signals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521611      PMCID: PMC1950474          DOI: 10.1016/j.bbrc.2007.05.017

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells.

Authors:  M K Tikkanen; D J Carter; A M Harris; H M Le; D O Azorsa; P S Meltzer; F E Murdoch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions.

Authors:  H H Zhao; R E Herrera; E Coronado-Heinsohn; M C Yang; J H Ludes-Meyers; K J Seybold-Tilson; Z Nawaz; D Yee; F G Barr; S G Diab; P H Brown; S A Fuqua; C K Osborne
Journal:  J Biol Chem       Date:  2001-05-15       Impact factor: 5.157

Review 3.  Minireview: nuclear receptor coactivators--an update.

Authors:  Neil J McKenna; Bert W O'Malley
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

4.  Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators.

Authors:  Aihua Zhang; Percy Luk Yeung; Chia-Wei Li; Shih-Chieh Tsai; Gia Khanh Dinh; Xiaoyang Wu; Hui Li; J Don Chen
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

5.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

6.  SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor.

Authors:  E J Park; D J Schroen; M Yang; H Li; L Li; J D Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 7.  The SRC family of nuclear receptor coactivators.

Authors:  C Leo; J D Chen
Journal:  Gene       Date:  2000-03-07       Impact factor: 3.688

8.  Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3.

Authors:  J Li; J Wang; J Wang; Z Nawaz; J M Liu; J Qin; J Wong
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

9.  Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse.

Authors:  W Huang; G L Sun; X S Li; Q Cao; Y Lu; G S Jiang; G S Jang; F Q Zhang; J R Chai; Z Y Wang; S Waxman
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

10.  ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.

Authors:  Maggie C Louie; June X Zou; Alina Rabinovich; Hong-Wu Chen
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

View more
  20 in total

1.  Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.

Authors:  Jason P Garee; Christopher D Chien; Jordan V Li; Anton Wellstein; Anna T Riegel
Journal:  Mol Endocrinol       Date:  2014-03-28

2.  Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia.

Authors:  Asli Sirmaci; Michail Spiliopoulos; Francesco Brancati; Eric Powell; Duygu Duman; Alex Abrams; Guney Bademci; Emanuele Agolini; Shengru Guo; Berrin Konuk; Asli Kavaz; Susan Blanton; Maria Christina Digilio; Bruno Dallapiccola; Juan Young; Stephan Zuchner; Mustafa Tekin
Journal:  Am J Hum Genet       Date:  2011-07-21       Impact factor: 11.025

3.  Characterization of ANKRD11 mutations in humans and mice related to KBG syndrome.

Authors:  Katherina Walz; Devon Cohen; Paul M Neilsen; Joseph Foster; Francesco Brancati; Korcan Demir; Richard Fisher; Michelle Moffat; Nienke E Verbeek; Kathrine Bjørgo; Adriana Lo Castro; Paolo Curatolo; Giuseppe Novelli; Clemer Abad; Cao Lei; Lily Zhang; Oscar Diaz-Horta; Juan I Young; David F Callen; Mustafa Tekin
Journal:  Hum Genet       Date:  2014-11-21       Impact factor: 4.132

4.  Identification of ANKRD11 and ZNF778 as candidate genes for autism and variable cognitive impairment in the novel 16q24.3 microdeletion syndrome.

Authors:  Marjolein H Willemsen; Bridget A Fernandez; Carlos A Bacino; Erica Gerkes; Arjan P M de Brouwer; Rolph Pfundt; Birgit Sikkema-Raddatz; Stephen W Scherer; Christian R Marshall; Lorraine Potocki; Hans van Bokhoven; Tjitske Kleefstra
Journal:  Eur J Hum Genet       Date:  2009-11-18       Impact factor: 4.246

Review 5.  Histone deacetylase-3: Friend and foe of the brain.

Authors:  Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

6.  Comprehensive analysis of clinical spectrum and genotype associations in Chinese and literature reported KBG syndrome.

Authors:  Qiuyue Li; Chengjun Sun; Lin Yang; Wei Lu; Feihong Luo
Journal:  Transl Pediatr       Date:  2021-04

7.  Familial intragenic duplication of ANKRD11 underlying three patients of KBG syndrome.

Authors:  Milena Crippa; Daniela Rusconi; Chiara Castronovo; Ilaria Bestetti; Silvia Russo; Anna Cereda; Angelo Selicorni; Lidia Larizza; Palma Finelli
Journal:  Mol Cytogenet       Date:  2015-03-26       Impact factor: 2.009

8.  Clinical significance of Ankyrin repeat domain 12 expression in colorectal cancer.

Authors:  Rui Bai; Dan Li; Zhong Shi; Xuefeng Fang; Weiting Ge; Shu Zheng
Journal:  J Exp Clin Cancer Res       Date:  2013-05-29

9.  Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors.

Authors:  Suvi Savola; Arto Klami; Abhishek Tripathi; Tarja Niini; Massimo Serra; Piero Picci; Samuel Kaski; Diana Zambelli; Katia Scotlandi; Sakari Knuutila
Journal:  BMC Cancer       Date:  2009-01-14       Impact factor: 4.430

10.  The molecular diversity of Luminal A breast tumors.

Authors:  Giovanni Ciriello; Rileen Sinha; Katherine A Hoadley; Anders S Jacobsen; Boris Reva; Charles M Perou; Chris Sander; Nikolaus Schultz
Journal:  Breast Cancer Res Treat       Date:  2013-10-06       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.